Gigi Hirsch

862 total citations
15 papers, 268 citations indexed

About

Gigi Hirsch is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Biomedical Engineering. According to data from OpenAlex, Gigi Hirsch has authored 15 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Biomedical Engineering. Recurrent topics in Gigi Hirsch's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (6 papers) and Biomedical Ethics and Regulation (4 papers). Gigi Hirsch is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (6 papers) and Biomedical Ethics and Regulation (4 papers). Gigi Hirsch collaborates with scholars based in United States, United Kingdom and Canada. Gigi Hirsch's co-authors include Nitin Patel, Mark Trusheim, Paul Gallo, José Cirı́aco Pinheiro, Pravin Chaturvedi, Michael Branson, Stacy L. Springs, Frank L. Douglas, Howard L. Golub and John J. Orloff and has published in prestigious journals such as Nature Reviews Drug Discovery, Science Translational Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gigi Hirsch

14 papers receiving 253 citations

Peers

Gigi Hirsch

PHYSI

PHEOH

Hanzhe Zhang China

Thorsten Vetter Netherlands

Robyn Lim Canada

Zhimin Yang China

Marisa Papaluca‐Amati Netherlands

Scott Askin Switzerland

Edward Abrahams United States

Kelly Plueschke Netherlands

Viktoriia Starokozhko Netherlands

Stephanie Van Bebber United States

Hanzhe Zhang China

Gigi Hirsch

81 ×0.6

33 ×0.8

53 ×1.3

18 ×0.5

PHYSI

33 ×0.9

PHEOH

Citations per year, relative to Gigi Hirsch Gigi Hirsch (= 1×) peers Hanzhe Zhang

Countries citing papers authored by Gigi Hirsch

Since Specialization

Citations

This map shows the geographic impact of Gigi Hirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gigi Hirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gigi Hirsch more than expected).

Fields of papers citing papers by Gigi Hirsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gigi Hirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gigi Hirsch. The network helps show where Gigi Hirsch may publish in the future.

Co-authorship network of co-authors of Gigi Hirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Gigi Hirsch. A scholar is included among the top collaborators of Gigi Hirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gigi Hirsch. Gigi Hirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hirsch, Gigi, Priscilla Velentgas, Jeffrey R. Curtis, et al.. (2023). Extending the vision of adaptive point-of-care platform trials to improve targeted use of drug therapy regimens: An agile approach in the learning healthcare system toolkit. Contemporary Clinical Trials. 133. 107327–107327.

Schaumberg, Debra A., et al.. (2023). Examining Endpoint Concordance in Clinical Trials and Real-World Clinical Practice to Advance Real-World Evidence Utilization. Therapeutic Innovation & Regulatory Science. 57(3). 472–475. 2 indexed citations

Eichler, Hans‐Georg, Mark Trusheim, Kay Larholt, et al.. (2021). Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict. Clinical Pharmacology & Therapeutics. 111(1). 52–62. 13 indexed citations

Hirsch, Gigi. (2018). Leaping Together Toward Sustainable, Patient‐Centered Innovation: The Value of a Multistakeholder Safe Haven for Accelerating System Change. Clinical Pharmacology & Therapeutics. 105(4). 798–801. 4 indexed citations

Lim, Robyn, John Ferguson, Marilyn Metcalf, et al.. (2018). Recognizing that Evidence is Made, not Born. Clinical Pharmacology & Therapeutics. 105(4). 844–856. 2 indexed citations

Hirsch, Gigi, Mark Trusheim, M Bala, et al.. (2016). Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need. Clinical Pharmacology & Therapeutics. 100(6). 685–698. 9 indexed citations

Baird, Lynn G., Mark Trusheim, Murray Lumpkin, et al.. (2015). Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation. Therapeutic Innovation & Regulatory Science. 50(3). 347–354. 11 indexed citations

Jain, Geetika, Ramy Arnaout, Jeffrey S. Brown, et al.. (2015). The next frontier: Fostering innovation by improving health data access and utilization. Clinical Pharmacology & Therapeutics. 98(5). 514–521. 6 indexed citations

Baird, L G, Reiner Banken, Finn Børlum Kristensen, et al.. (2014). Accelerated Access to Innovative Medicines for Patients in Need. Clinical Pharmacology & Therapeutics. 96(5). 559–571. 64 indexed citations

10.

Teagarden, J. Russell, et al.. (2014). Access and availability of orphan drugs in the United States: advances or cruel hoaxes?. Expert Opinion on Orphan Drugs. 2(11). 1147–1150. 5 indexed citations

11.

Trusheim, Mark, Lynn G. Baird, Sarah Garner, et al.. (2014). The Janus initiative: A multi-stakeholder process and tool set for facilitating and quantifying Adaptive Licensing discussions. Health Policy and Technology. 3(4). 241–247. 6 indexed citations

12.

Baird, Lynn G., Mark Trusheim, Hans‐Georg Eichler, Ernst R. Berndt, & Gigi Hirsch. (2013). Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development. Therapeutic Innovation & Regulatory Science. 47(4). 474–483. 12 indexed citations

13.

Hirsch, Gigi, et al.. (2013). Curing Consortium Fatigue. Science Translational Medicine. 5(200). 200fs35–200fs35. 23 indexed citations

14.

Hirsch, Gigi. (2013). Gigi Hirsch. Nature Reviews Drug Discovery. 13(1). 14–14. 1 indexed citations

15.

Orloff, John J., Frank L. Douglas, José Cirı́aco Pinheiro, et al.. (2009). The future of drug development: advancing clinical trial design. Nature Reviews Drug Discovery. 8(12). 949–957. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact